Transfusion in critically ill children: an ongoing dilemma

Area of Science:

• Pediatric critical care medicine
• Hematology
• Transfusion medicine

Background:

• Blood product transfusion is vital for critically ill children but carries risks.
• Current pediatric transfusion practices often lack strong evidence, relying on adult data and expert opinion.
• Critically ill children face unique physiological challenges, including anemia and iatrogenic blood loss, increasing transfusion risks.

Purpose of the Study:

• To review the benefits and adverse effects of blood product transfusion in critically ill children.
• To evaluate current transfusion practices against available evidence.
• To assess the appropriateness of restrictive transfusion strategies in pediatric patients.

Main Methods:

• A comprehensive literature review of 65 selected papers.
• Evaluation of studies based on pre-defined selection criteria.
• Analysis of evidence regarding transfusion triggers and patient outcomes.

Main Results:

• Transfusion in children is linked to increased morbidity.
• A restrictive transfusion strategy (hemoglobin threshold of 70 g/L) showed no increased harm compared to liberal triggers (95 g/L) in most stable pediatric cases.
• Cyanotic children and neonates were excluded from this specific finding.

Conclusions:

• Blood transfusion in pediatric patients should be viewed as high-risk and requires individualized assessment.
• A restrictive transfusion approach is generally appropriate for critically ill children, balancing necessity against associated risks.
• Further evidence-based guidelines are needed for pediatric transfusion practices.